ZYDUS FAMILY TRUST Administrative Office: “Zydus Corporate Park”, Scheme No

ZYDUS FAMILY TRUST Administrative Office: “Zydus Corporate Park”, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Near Vaishnodevi Circle, Sarkhej–Gandhinagar Highway, Ahmedabad–382481

Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find enclosed disclosure of shares held by Zydus Family Trust in Cadila Healthcare Limited, the Target Company, in the prescribed format as on March 31, 2020, pursuant to Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011.

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully, For, ZYDUS FAMILY TRUST

Sd/‐ PANKAJ R. PATEL TRUSTEE

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited 2. Name[s] of the Stock Exchange[s] where 1. National Stock Exchange of India Limited the shares of the TC are listed 2. BSE Limited

3. Particulars of the shareholder a. Name of person whose total holding Zydus Family Trust [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC; Or b. Name[s] of promoter[s], member of the promoter group and Persons Zydus Family Trust Acting in Concert [PAC] with him. 4 Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / diluted voting share/ voting capital capital of wherever TC(*) applicable 5. As on March 31, 2020, holding of: [a] Shares 766381434 74.86 74.86 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Nil [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 76638143474.86 74.86

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and PACs Persons Acting in Concert to Promoter / Promoter (PAC) with the person group Zydus Family Trust Promoter Group AAATZ0092P

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

For, ZYDUS FAMILY TRUST

Sd/‐ PANKAJ R. PATEL TRUSTEE

Place: Ahmedabad Date: May 11, 2020 Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find enclosed disclosure of shares held by me in Cadila Healthcare Limited, the Target Company, in the prescribed format as on March 31, 2020, pursuant to Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011.

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______SHIVANI P. PATEL

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] 1. National Stock Exchange of India Limited. where the shares of the TC are listed 2. BSE Limited.

3. Particulars of the shareholder a. Name of person whose total holding N.A. [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member of the promoter group and Persons Shivani Pankajbhai Patel Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital share/voting wherever capital of TC(*) applicable 5. As on March 31, 2020, holding of: [a] Shares 15,000 0.001 0.001 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Ni l [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 15,000 0.001 0.001

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and Persons Acting in Concert to Promoter / Promoter PACs (PAC) with the person group

Shivani Pankajbhai Patel Promoter Group ABCPP1505C

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______SHIVANI P. PATEL

Place: Ahmedabad Date: May 11, 2020

Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______PRITIBEN P. PATEL

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] National Stock Exchange of India Limited where the shares of the TC are listed BSE Limited

3. Particulars of the shareholder a. Name of person whose total holding N.A. [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member of the promoter group and Persons Pritiben Pankajbhai Patel Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital share/voting wherever capital of applicable TC(*) 5. As on March 31, 2020, holding of: [a] Shares 15000 0.001 0.001 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Nil [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 15000 0.001 0.001

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and PACs Persons Acting in Concert to Promoter / Promoter (PAC) with the person group Pritiben Pankajbhai Patel Promoter group AAMPP3673L

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______PRITIBEN P. PATEL

Place: Ahmedabad Date: May 11, 2020

PRIPAN INVESTMENT PRIVATE LIMITED Regd. Office: 16, Azad Society Ambawadi Ahmedabad ‐ 380 015 CIN: U65910GJ1980PTC004056

Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find enclosed disclosure of shares held by Pripan Investment Private Limited in Cadila Healthcare Limited, the Target Company as on March 31, 2020, in the prescribed format, pursuant to Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011.

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully, For, PRIPAN INVESTMENT PRIVATE LIMITED

Sd/‐

KARAN PATEL COMPANY SECRETARY

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011.

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] where 1. National Stock Exchange of India Limited the shares of the TC are listed 2. BSE Limited

3. Particulars of the shareholder a. Name of person whose total N.A. holding [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member Pripan Investment Private Limited of the promoter group and Persons Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital wherever share/voting applicable capital of TC(*) 5. As on March 31, 2020, holding of: [a] Shares 18,000 0.002 0.002 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Nil [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 18,000 0.002 0.002

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Persons Whether the person PAN of the person and Acting in Concert (PAC) with the belongs to Promoter / PACs person Promoter group Pripan Investment Private LimitedPromoter group AAACP9017B

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

For, PRIPAN INVESTMENT PRIVATE LIMITED

Sd/‐

KARAN PATEL COMPANY SECRETARY

Place: Ahmedabad Date: May 11, 2020

Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______PANKAJ R. PATEL

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1. Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] 1. National Stock Exchange of India Limited where the shares of the TC are listed 2. BSE Limited

3. Particulars of the shareholder a. Name of person whose total N.A. holding [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member of the promoter group and Persons Pankaj Ramanbhai Patel Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital share/votin wherever g capital of applicable TC(*) 5. As on March 31, 2020, holding of: [a] Shares 15,000 0.001 0.001 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Nil [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 15,000 0.001 0.001

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and PACs Persons Acting in Concert to Promoter / Promoter (PAC) with the person group Pankaj Ramanbhai Patel Promoter AFUPP4143C

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______PANKAJ R. PATEL

Place: Ahmedabad Date: May 11, 2020 Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______SHARVIL P. PATEL

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited 2. Name[s] of the Stock Exchange[s] where 1. National Stock Exchange of India Limited the shares of the TC are listed 2. BSE Limited

3. Particulars of the shareholder a. Name of person whose total N.A. holding [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member Sharvil Pankajbhai Patel of the promoter group and Persons Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital share/ wherever voting applicable capital of TC(*) 5. As on March 31, 2020, holding of: [a] Shares 15,000 0.001 0.001 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Nil [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 15,000 0.001 0.001

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and Persons Acting in Concert to Promoter / Promoter PACs (PAC) with the person group

Sharvil Pankajbhai Patel Promoter ABCPP1507A

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______SHARVIL P. PATEL

Place: Ahmedabad Date: May 11, 2020 Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find enclosed disclosure of shares held by me, as a Trustee of Taraben Patel Family Will Trust, in Cadila Healthcare Limited, the Target Company, in the prescribed format as on March 31, 2020, pursuant to Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011.

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______PANKAJ R. PATEL Trustee–Taraben Patel Family Will Trust

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] where 1. National Stock Exchange of India Limited the shares of the TC are listed 2. BSE Limited

3. Particulars of the shareholder a. Name of person whose total N.A. holding [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member Pankaj R. Patel ‐ Trustee of the promoter group and Persons Taraben Patel Family Will Trust Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital wherever share/voting applicable capital of TC(*) 5. As on March 31, 2020, holding of: [a] Shares 15,000 0.001 0.001 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Ni l [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 15,000 0.001 0.001

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and Persons Acting in Concert to Promoter / Promoter PACs (PAC) with the person group

Pankaj R. Patel – Trustee Promoter group AACTT7030K Taraben Patel Family Will Trust

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______PANKAJ R. PATEL TRUSTEE–TARABEN PATEL FAMILY WILL TRUST

Place: Ahmedabad Date: May 11, 2020 Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find enclosed disclosure of shares held by R B Patel Will Pankaj Trust in Cadila Healthcare Limited, the Target Company, in the prescribed format as on March 31, 2020, pursuant to Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011.

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______PANKAJ R. PATEL TRUSTEE–R B PATEL WILL PANKAJ TRUST

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] 1. National Stock Exchange of India Limited where the shares of the TC are listed 2. BSE Limited

3. Particulars of the shareholder a. Name of person whose total holding N.A. [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member of Pankaj Ramanbhai Patel the promoter group and Persons (R. B. Patel will Pankaj Trust) Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital share/voting wherever capital of applicable TC(*) 5. As on March 31, 2020, holding of: [a] Shares 15,000 0.001 0.001 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Ni l [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 15,000 0.001 0.001

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and PACs Persons Acting in Concert to Promoter / Promoter (PAC) with the person group Pankaj Ramanbhai Patel PromoterAFUPP4143C (R. B. Patel will Pankaj Trust)

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______PANKAJ R. PATEL TRUSTEE–R B PATEL WILL PANKAJ TRUST

Place: Ahmedabad Date: May 11, 2020

Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find enclosed disclosure of shares held by Pankaj R. Patel Smaller HUF in Cadila Healthcare Limited, the Target Company, in the prescribed format as on March 31, 2020, pursuant to Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011.

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______PANKAJ R. PATEL KARTA–PANKAJ R. PATEL SMALLER HUF

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] 1. National Stock Exchange of India Limited where the shares of the TC are listed 2. BSE Limited

3. Particulars of the shareholder a. Name of person whose total N.A. holding [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member of the promoter group and Persons Pankaj Ramanbhai Patel Acting in Concert [PAC] with him. (P. R. Patel–Smaller HUF) 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital share/voting wherever capital of applicable TC(*) 5. As on March 31, 2020, holding of: [a] Shares 15,000 0.001 0.001 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Nil [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 15,000 0.001 0.001

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______PANKAJ R. PATEL KARTA–P R PATEL SMALLER HUF

Place: Ahmedabad Date: May 11, 2020 Date: May 11, 2020

Listing Department BOMBAY STOCK EXCHANGE LIMITED P J Towers, Dalal Street, Fort, Mumbai–400 001

Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai–400 051

Re.: Disclosure under Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011

Dear Sir,

Please find enclosed disclosure of shares held by Pankaj Ramanbhai Patel [HUF] in Cadila Healthcare Limited, the Target Company, in the prescribed format as on March 31, 2020, pursuant to Regulation 30[1] & 30[2] of SEBI [Substantial Acquisition of Shares & Takeovers] Regulations, 2011.

Please find the same in order and take the same on record.

Thanking you,

Yours faithfully,

Sd/‐ ______PANKAJ R. PATEL–KARTA OF HUF

Encl.: As above

Copy to: The Company Secretary, Cadila Healthcare Limited

DISCLOSURES UNDER REGULATION 30[2] OF SEBI [SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS] REGULATIONS, 2011

Part–A–Details of Shareholding

1 Name of the Target Company [TC] Cadila Healthcare Limited

2. Name[s] of the Stock Exchange[s] where 1. National Stock Exchange of India Limited the shares of the TC are listed 2. Bombay Stock Exchange Limited

3. Particulars of the shareholder a. Name of person whose total holding N.A. [including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company] is more than 25% of the shares or voting rights of the TC Or b. Name[s] of promoter[s], member of the promoter group and Persons Pankaj Ramanbhai Patel‐HUF Acting in Concert [PAC] with him. 4. Particulars of the holding of persons Number % w.r.t. total % of total mentioned at [3] above share / voting diluted capital share/voting wherever capital of applicable TC(*) 5. As on March 31, 2020, holding of: [a] Shares 30,000 0.003 0.003 [b] Voting Rights [otherwise than by Nil shares] [c] Warrants Nil [d] Convertible Securities Nil [e] Any other instrument that would Nil entitle the holder to receive shares in the TC. Total 30,000 0.003 0.003

Part‐B**

Name of the Target Company: Cadila Healthcare Limited

Name(s) of the person and Whether the person belongs PAN of the person and PACs Persons Acting in Concert to Promoter / Promoter (PAC) with the person group Pankaj Ramanbhai Patel‐ Promoter groupAADHP8061M HUF

Note:

1. In case of promoter(s) making disclosure under Regulation 30(2), no additional disclosure under Regulation 30(1) is required.

[*] Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC

[**] Part‐B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Sd/‐ ______PANKAJ R. PATEL KARTA–PANKAJ R. PATEL HUF

Place: Ahmedabad Date: May 11, 2020